JOHNSON & JOHNSON — Director's Dealing 2025

Feb 12, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-02-07

Reporting Person: Taubert Jennifer L (EVP, WWC. Innovative Medicine)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-07	Common Stock	M	58504	$100.06	Acquired	213355.001	Direct
2025-02-07	Common Stock	F	47436	$153.12	Disposed	165919.001	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-07	Employee Stock Options (Right to Buy)	$100.06	M	58504	Disposed	2025-02-09	Common Stock (58504)	Direct

Footnotes

F1: Reflects the auto-exercise of options immediately prior to their expiration.

F2: Shares withheld for payment of the exercise price and taxes in connection with the exercise of the options reported on this Form 4.